live

bselive
nselive

Volume

Todays L/H

Reported Consolidated quarterly numbers for Bliss GVS Pharma are:

Net Sales at Rs 151.54 crore in September 2020 down 27.88% from Rs. 210.12 crore in September 2019.

Quarterly Net Profit at Rs. 20.51 crore in September 2020 down 33.81% from Rs. 30.98 crore in September 2019.

EBITDA stands at Rs. 34.74 crore in September 2020 down 9.46% from Rs. 38.37 crore in September 2019.

Bliss GVS EPS has decreased to Rs. 1.99 in September 2020 from Rs. 3.00 in September 2019.

Bliss GVS shares closed at 172.85 on October 26, 2020 (NSE) and has given 73.72% returns over the last 6 months and 24.44% over the last 12 months.

Bliss GVS Pharma
Consolidated Quarterly Results	in Rs. Cr.

	Sep'20	Jun'20	Sep'19
Net Sales/Income from operations	151.54	129.55	210.12
Other Operating Income	--	--	--
Total Income From Operations	151.54	129.55	210.12
EXPENDITURE
Consumption of Raw Materials	74.41	44.11	69.85
Purchase of Traded Goods	15.44	36.51	85.01
Increase/Decrease in Stocks	-8.66	-1.18	0.97
Power & Fuel	--	--	--
Employees Cost	15.72	16.03	14.32
Depreciation	4.31	4.29	3.50
Excise Duty	--	--	--
Admin. And Selling Expenses	--	--	--
R & D Expenses	--	--	--
Provisions And Contingencies	--	--	--
Exp. Capitalised	--	--	--
Other Expenses	22.63	14.60	14.50
P/L Before Other Inc., Int., Excpt. Items & Tax	27.69	15.19	21.97
Other Income	2.74	7.04	12.90
P/L Before Int., Excpt. Items & Tax	30.43	22.23	34.87
Interest	0.38	1.83	1.05
P/L Before Exceptional Items & Tax	30.05	20.40	33.81
Exceptional Items	--	--	--
P/L Before Tax	30.05	20.40	33.81
Tax	8.44	3.75	2.95
P/L After Tax from Ordinary Activities	21.61	16.65	30.86
Prior Year Adjustments	--	--	--
Extra Ordinary Items	--	--	--
Net Profit/(Loss) For the Period	21.61	16.65	30.86
Minority Interest	-1.10	-0.46	0.12
Share Of P/L Of Associates	--	--	--
Net P/L After M.I & Associates	20.51	16.19	30.98
Equity Share Capital	10.31	10.31	10.31
Reserves Excluding Revaluation Reserves	--	--	--
Equity Dividend Rate (%)	--	--	--
EPS Before Extra Ordinary
Basic EPS	1.99	1.57	3.00
Diluted EPS	1.95	1.54	3.00
EPS After Extra Ordinary
Basic EPS	2.10	1.57	3.00
Diluted EPS	1.95	1.54	3.00
Public Share Holding
No Of Shares (Crores)	--	--	--
Share Holding (%)	--	--	--
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)	--	--	--
- Per. of shares (as a % of the total sh. of prom. and promoter group)	--	--	--
- Per. of shares (as a % of the total Share Cap. of the company)	--	--	--
b) Non-encumbered
- Number of shares (Crores)	--	--	--
- Per. of shares (as a % of the total sh. of prom. and promoter group)	--	--	--
- Per. of shares (as a % of the total Share Cap. of the company)	--	--	--
Source : Dion Global Solutions Limited

First Published on Oct 27, 2020 09:41 am

Bliss GVS Consolidated September 2020 Net Sales at Rs 151.54 crore, down 27.88% Y-o-Y

tags #Bliss GVS #Bliss GVS Pharma #Earnings First-Cut #Pharmaceuticals #Results